Crinetics Pharmaceuticals Inc. (CRNX) NASDAQ

$43.66 (0.93) (-2.09%)

Market Cap: $3.10B

As of 04/15/24 03:59 PM EDT. Market closed.

(CRNX)

Crinetics Pharmaceuticals Inc. (CRNX)
NASDAQ

$43.66
(0.93) (-2.09%)

Market Cap: $3.10B

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our ... read more

neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
R. Scott Struthers
Full Time Employees
194
CEO Compensation (Base)
$409,913
CEO Compensation (Total)
$3.04M
URL
Address
10222 Barnes Canyon Rd Bldg 2, California, San Diego, 92121-2711.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
R. Scott Struthers
Full Time Employees
194
CEO Compensation (Base)
$409,913
CEO Compensation (Total)
$3.04M
Address
10222 Barnes Canyon Rd Bldg 2, California, San Diego, 92121-2711.
PRICE CHART FOR CRINETICS PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$44.24
Previous Close
$44.59
Days Range
$43.75 - $48
52 week range
$15.76 - $49.58
Volume
540,698
Avg. Volume (30 days)
1,115,994
Market Cap
$3.10B
Dividend Yield
-
P/E
(14.47)
Shares Outstanding
69,600,000
Open
$44.24
Previous Close
$44.59
Days Range
$43.75 - $48
52 week range
$15.76 - $49.58
Volume
540,698
Avg. Volume (30 days)
1,115,994
Market Cap
$3.10B
Dividend Yield
-
P/E
(14.47)
Shares Outstanding
69,600,000
FINANCIAL STATEMENTS FOR CRINETICS PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CRINETICS PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Struthers Richard ScottPresident & CEOApr 04, 2024 Option Exercise$9.2840,951380,025278,786Apr 08, 2024, 05:09 PM
Struthers Richard ScottPresident & CEOApr 04, 2024 Sale$49.1740,9512,013,561237,835Apr 08, 2024, 05:09 PM
Knight Jeff E.Chief Operating OfficerMar 22, 2024 Option Exercise$23.9830,000719,40084,939Mar 26, 2024, 04:30 PM
Knight Jeff E.Chief Operating OfficerMar 22, 2024 Sale$44.3132,3591,433,67554,939Mar 26, 2024, 04:30 PM
Pizzuti DanaChief Med and Dev OfficerMar 20, 2024 Option Exercise$16.8914,375242,79438,500Mar 22, 2024, 04:52 PM
Pizzuti DanaChief Med and Dev OfficerMar 20, 2024 Sale$44.0615,089664,76328,500Mar 22, 2024, 04:52 PM
Fust Matthew KDirectorMar 20, 2024 Option Exercise$20.9260,0001,254,97536,036Mar 22, 2024, 04:31 PM
Fust Matthew KDirectorMar 20, 2024 Sale$44.1460,0002,648,15018,536Mar 22, 2024, 04:31 PM
Pizzuti DanaChief Med and Dev OfficerMar 18, 2024 Option Exercise$38.1441115,67628,500Mar 20, 2024, 06:36 PM
Knight Jeff E.Chief Operating OfficerMar 18, 2024 Option Exercise$38.144,283163,35454,939Mar 20, 2024, 06:35 PM
Hassard JamesChief Commercial OfficerMar 18, 2024 Option Exercise$38.141,74166,40229,259Mar 20, 2024, 06:34 PM
Betz Stephen F.Chief Scientific OfficerMar 18, 2024 Option Exercise$38.143,655139,40292,643Mar 20, 2024, 06:33 PM
Wilson MarcCFOMar 18, 2024 Option Exercise$38.143,983151,912117,572Mar 20, 2024, 06:32 PM
Wilson MarcCFOMar 19, 2024 Sale$42.916,942297,881110,630Mar 20, 2024, 06:32 PM
Struthers Richard ScottPresident & CEOMar 18, 2024 Option Exercise$38.1412,687483,882237,835Mar 20, 2024, 06:31 PM
Betz Stephen F.Chief Scientific OfficerJan 25, 2024 Sale$37.263,000111,78073,298Jan 26, 2024, 05:50 PM
Betz Stephen F.Chief Scientific OfficerJan 10, 2024 Sale$37.653,000112,95076,298Jan 12, 2024, 04:12 PM
Pizzuti DanaChief Med and Dev OfficerJan 03, 2024 Option Exercise$16.8914,375242,79420,286Jan 04, 2024, 04:45 PM
Pizzuti DanaChief Med and Dev OfficerJan 03, 2024 Sale$35.0014,375503,1255,911Jan 04, 2024, 04:45 PM
Wilson MarcCFOJan 02, 2024 Option Exercise$9.2810,00092,800106,055Jan 04, 2024, 04:43 PM
Wilson MarcCFOJan 02, 2024 Sale$35.4710,000354,70096,055Jan 04, 2024, 04:43 PM
Betz Stephen F.Chief Scientific OfficerDec 26, 2023 Sale$35.893,000107,67079,298Dec 27, 2023, 05:20 PM
Pizzuti DanaChief Med and Dev OfficerDec 21, 2023 Option Exercise$16.899,583161,85715,494Dec 22, 2023, 06:45 PM
Pizzuti DanaChief Med and Dev OfficerDec 21, 2023 Sale$34.579,583331,2845,911Dec 22, 2023, 06:45 PM
Betz Stephen F.Chief Scientific OfficerDec 11, 2023 Sale$32.873,00098,61082,298Dec 13, 2023, 04:44 PM
Betz Stephen F.Chief Scientific OfficerNov 27, 2023 Sale$31.843,00095,52085,298Nov 29, 2023, 04:31 PM
Struthers Richard ScottPresident & CEONov 09, 2023 Option Exercise$1.9150,00095,500185,522Nov 13, 2023, 04:33 PM
Struthers Richard ScottPresident & CEONov 02, 2023 Option Exercise$9.289188,519136,440Nov 06, 2023, 06:02 PM
Struthers Richard ScottPresident & CEONov 03, 2023 Option Exercise$9.28199,0821,847,481334,604Nov 06, 2023, 06:02 PM
Struthers Richard ScottPresident & CEONov 02, 2023 Sale$29.9591827,494135,522Nov 06, 2023, 06:02 PM
Struthers Richard ScottPresident & CEONov 03, 2023 Sale$30.56199,0826,083,946135,522Nov 06, 2023, 06:02 PM
Wilson MarcCFONov 01, 2023 Option Exercise$9.2810,00092,800105,601Nov 03, 2023, 07:38 PM
Wilson MarcCFONov 01, 2023 Sale$28.7510,000287,50095,601Nov 03, 2023, 07:38 PM
Krasner Alan SethChief Medical OfficerOct 17, 2023 Option Exercise$12.017,00084,07050,210Oct 19, 2023, 05:01 PM
Krasner Alan SethChief Medical OfficerOct 17, 2023 Sale$30.007,000210,00043,210Oct 19, 2023, 05:01 PM
Struthers Richard ScottPresident & CEOAug 14, 2023 Option Exercise$1.9110,00019,100135,522Aug 16, 2023, 04:30 PM
Struthers Richard ScottPresident & CEOJul 13, 2023 Sale$20.3514,157288,095630,805Jul 13, 2023, 04:56 PM
Struthers Richard ScottPresident & CEOJul 12, 2023 Sale$20.1711,459231,128644,962Jul 13, 2023, 04:56 PM
Struthers Richard ScottPresident & CEOJul 11, 2023 Sale$20.1424,384491,094656,421Jul 13, 2023, 04:56 PM
Wilson MarcCFOJun 20, 2023 Option Exercise$9.2820,000185,600115,158Jun 21, 2023, 05:32 PM
Wilson MarcCFOJun 20, 2023 Sale$19.9730,922617,40395,158Jun 21, 2023, 05:32 PM
Struthers Richard ScottPresident & CEOJun 16, 2023 Sale$20.8150,0001,040,500680,805Jun 21, 2023, 05:27 PM
Vivaldi Coelho RogerioDirectorJun 08, 2023 Buy$22.065,000110,3005,000Jun 09, 2023, 08:00 AM
Pizzuti DanaChief Development OfficerApr 03, 2023 Option Exercise$15.984,28868,52212,712Apr 05, 2023, 07:12 PM
Pizzuti DanaChief Development OfficerApr 05, 2023 Sale$16.158,212132,6244,500Apr 05, 2023, 07:12 PM
Wilson MarcCFOMar 16, 2023 Option Exercise$17.121,66628,522106,080Mar 17, 2023, 05:11 PM
Struthers Richard ScottPresident & CEOMar 16, 2023 Option Exercise$17.124,62879,231125,522Mar 17, 2023, 05:10 PM
Krasner Alan SethChief Medical OfficerMar 16, 2023 Option Exercise$17.121,68728,88142,301Mar 17, 2023, 05:09 PM
Knight Jeff E.Chief Operating OfficerMar 16, 2023 Option Exercise$17.1258710,04934,400Mar 17, 2023, 05:08 PM
Betz Stephen F.Chief Scientific OfficerMar 16, 2023 Option Exercise$17.121,41024,13986,879Mar 17, 2023, 05:07 PM
Betz Stephen F.Chief Scientific OfficerFeb 01, 2023 Sale$19.593,12661,23864,689Feb 03, 2023, 04:30 PM
Betz Stephen F.Chief Scientific OfficerJan 25, 2023 Sale$21.078,336175,64067,815Jan 27, 2023, 04:26 PM
Betz Stephen F.Chief Scientific OfficerJan 17, 2023 Sale$18.003,12656,26876,151Jan 19, 2023, 04:28 PM
Betz Stephen F.Chief Scientific OfficerJan 03, 2023 Sale$18.353,12657,36279,277Jan 05, 2023, 04:23 PM
Betz Stephen F.Chief Scientific OfficerDec 15, 2022 Sale$16.003,12650,01682,403Dec 19, 2022, 05:11 PM
Betz Stephen F.Chief Scientific OfficerDec 01, 2022 Sale$17.843,12655,76884,968Dec 05, 2022, 05:28 PM
Betz Stephen F.Chief Scientific OfficerNov 15, 2022 Sale$18.723,12658,51988,094Nov 17, 2022, 04:46 PM
Betz Stephen F.Chief Scientific OfficerNov 01, 2022 Sale$18.523,12657,89491,220Nov 03, 2022, 04:35 PM
Betz Stephen F.Chief Scientific OfficerOct 17, 2022 Sale$17.733,12655,42494,346Oct 19, 2022, 05:34 PM
Struthers Richard ScottPresident & CEOOct 12, 2022 Option Exercise$1.9111,10021,20168,500Oct 14, 2022, 04:55 PM
Betz Stephen F.Chief Scientific OfficerOct 03, 2022 Sale$19.643,12661,39597,472Oct 05, 2022, 04:40 PM
Betz Stephen F.Chief Scientific OfficerSep 15, 2022 Sale$21.014,16887,570100,598Sep 19, 2022, 04:40 PM
Betz Stephen F.Chief Scientific OfficerSep 07, 2022 Sale$21.001,04221,884104,766Sep 09, 2022, 04:20 PM
Betz Stephen F.Chief Scientific OfficerMay 20, 2022 Option Exercise$11.021,33614,723108,934Sep 06, 2022, 04:20 PM
Betz Stephen F.Chief Scientific OfficerSep 01, 2022 Sale$18.593,12658,112105,808Sep 06, 2022, 04:20 PM
Knight Jeff E.Chief Operating OfficerMay 20, 2022 Option Exercise$17.441,15220,0916,102Jul 29, 2022, 04:26 PM
Knight Jeff E.Chief Operating OfficerJul 26, 2022 Sale$20.701,15223,8474,950Jul 29, 2022, 04:26 PM
Fust Matthew KDirectorJul 13, 2022 Option Exercise$1.455,7008,26518,236Jul 15, 2022, 04:30 PM
Fust Matthew KDirectorJul 13, 2022 Sale$20.965,700119,45512,536Jul 15, 2022, 04:30 PM
Betz Stephen F.Chief Scientific OfficerMay 02, 2022 Sale$20.103,24765,252107,598May 04, 2022, 05:01 PM
Betz Stephen F.Chief Scientific OfficerApr 18, 2022 Sale$25.815,664146,188110,845Apr 21, 2022, 05:00 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 18, 2022 Buy$22.22157,5153,499,9835,321,032Apr 18, 2022, 05:39 PM
Struthers Richard ScottPresident & CEOApr 13, 2022 Sale$26.83138,6433,719,625844,774Apr 15, 2022, 06:00 PM
Struthers Richard ScottPresident & CEOApr 05, 2022 Sale$25.3421,357541,225869,448Apr 07, 2022, 05:58 PM
Betz Stephen F.Chief Scientific OfficerApr 04, 2022 Sale$23.979,000215,761116,509Apr 06, 2022, 07:08 PM
Betz Stephen F.Chief Scientific OfficerApr 01, 2022 Sale$21.804,16490,775125,509Apr 01, 2022, 05:39 PM
Betz Stephen F.Chief Scientific OfficerMar 31, 2022 Sale$21.064,16487,700129,673Apr 01, 2022, 05:39 PM
Betz Stephen F.Chief Scientific OfficerMar 15, 2022 Sale$18.943,12359,150133,837Mar 17, 2022, 04:33 PM
Madan AjayChief Development OfficerMar 01, 2022 Sale$19.889,000178,920176,995Mar 02, 2022, 09:00 PM
Betz Stephen F.Chief Scientific OfficerMar 01, 2022 Sale$19.733,12361,617136,960Mar 02, 2022, 09:00 PM
Betz Stephen F.Chief Scientific OfficerFeb 15, 2022 Sale$18.643,12358,213123,583Feb 17, 2022, 04:34 PM
Madan AjayChief Development OfficerFeb 07, 2022 Sale$17.8313,411239,085172,045Feb 09, 2022, 05:00 PM
Betz Stephen F.Chief Scientific OfficerFeb 01, 2022 Sale$18.793,12358,681126,706Feb 03, 2022, 04:30 PM
Krasner Alan SethChief Medical OfficerJan 19, 2022 Option Exercise$12.016,70080,46715,011Jan 21, 2022, 04:54 PM
Krasner Alan SethChief Medical OfficerJan 19, 2022 Sale$21.216,700142,0808,311Jan 21, 2022, 04:54 PM
Betz Stephen F.Chief Scientific OfficerJan 18, 2022 Sale$23.294,16897,073128,875Jan 20, 2022, 04:47 PM
Betz Stephen F.Chief Scientific OfficerJan 03, 2022 Sale$28.027,168200,847133,043Jan 06, 2022, 04:37 PM
Betz Stephen F.Chief Scientific OfficerDec 28, 2021 Sale$27.953,00083,852140,211Dec 30, 2021, 07:19 PM
Betz Stephen F.Chief Scientific OfficerDec 15, 2021 Sale$24.145,668136,826143,211Dec 17, 2021, 04:28 PM
Betz Stephen F.Chief Scientific OfficerDec 01, 2021 Sale$27.385,668155,190148,879Dec 03, 2021, 04:36 PM
Betz Stephen F.Chief Scientific OfficerNov 16, 2021 Sale$27.971,50041,955154,547Nov 17, 2021, 05:01 PM
Betz Stephen F.Chief Scientific OfficerNov 15, 2021 Sale$26.755,668151,619156,047Nov 17, 2021, 05:01 PM
Betz Stephen F.Chief Scientific OfficerNov 08, 2021 Sale$28.423,900110,846161,715Nov 09, 2021, 05:44 PM
Betz Stephen F.Chief Scientific OfficerNov 05, 2021 Sale$27.9512,600352,195165,615Nov 09, 2021, 05:44 PM
Betz Stephen F.Chief Scientific OfficerNov 01, 2021 Sale$24.795,668140,510178,215Nov 03, 2021, 04:57 PM
Fust Matthew KDirectorNov 01, 2021 Option Exercise$1.918,95417,10221,490Nov 03, 2021, 04:55 PM
Fust Matthew KDirectorNov 01, 2021 Sale$25.508,954228,32712,536Nov 03, 2021, 04:55 PM
Madan AjayChief Development OfficerOct 28, 2021 Option Exercise$0.73106,38377,660184,671Nov 01, 2021, 07:11 PM
Betz Stephen F.Chief Scientific OfficerOct 27, 2021 Sale$24.003,00071,991183,883Oct 28, 2021, 05:00 PM
Betz Stephen F.Chief Scientific OfficerOct 21, 2021 Sale$21.101,04221,984186,883Oct 25, 2021, 04:28 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 25, 2021 Buy$19.801,200,00023,759,9995,163,517Oct 25, 2021, 02:47 PM
Fust Matthew KDirectorSep 08, 2021 Option Exercise$1.916,04611,54818,582Sep 09, 2021, 05:00 PM
Fust Matthew KDirectorSep 08, 2021 Sale$25.506,046154,17312,536Sep 09, 2021, 05:00 PM
Struthers Richard ScottPresident & CEOSep 07, 2021 Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
Struthers Richard ScottPresident & CEOSep 07, 2021 Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
Struthers Richard ScottPresident & CEOSep 07, 2021 Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
Fust Matthew KDirectorJul 26, 2021 Option Exercise$1.915,0009,55017,536Jul 27, 2021, 08:00 PM
Fust Matthew KDirectorJul 26, 2021 Sale$19.595,00097,95012,536Jul 27, 2021, 08:00 PM
Fust Matthew KDirectorJul 19, 2021 Option Exercise$1.915,0009,55017,536Jul 20, 2021, 05:00 PM
Fust Matthew KDirectorJul 19, 2021 Sale$19.505,00097,50012,536Jul 20, 2021, 05:00 PM
Fust Matthew KDirectorJul 12, 2021 Option Exercise$1.915,0009,55017,536Jul 13, 2021, 05:00 PM
Fust Matthew KDirectorJul 12, 2021 Sale$20.715,000103,55012,536Jul 13, 2021, 05:00 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 08, 2021 Buy$16.44304,1364,999,9963,963,517Apr 09, 2021, 09:00 AM
Struthers Richard ScottPresident & CEODec 03, 2020 Buy$13.104,00052,4004,000Dec 04, 2020, 04:59 PM
Struthers Richard ScottPresident & CEODec 02, 2020 Buy$12.601,00012,6001,000Dec 04, 2020, 04:59 PM
Struthers Richard ScottPresident & CEOJul 16, 2020 Sale$14.4617,500253,108890,805Jul 17, 2020, 05:05 PM
Struthers Richard ScottPresident & CEOJul 15, 2020 Sale$15.3017,500267,722908,305Jul 17, 2020, 05:05 PM
WIERENGA WENDALLDirectorApr 28, 2020 Option Exercise$0.7325,32918,49099,846Apr 29, 2020, 05:01 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 17, 2020 Buy$14.001,071,42814,999,9923,659,381Apr 20, 2020, 08:30 AM
Vivo Capital VIII, LLC10% OwnerApr 17, 2020 Sale$15.4084,5981,302,8092,162,587Apr 17, 2020, 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 16, 2020 Sale$15.2030,190458,8882,236,920Apr 17, 2020, 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 15, 2020 Sale$15.50215,8103,345,0552,263,447Apr 17, 2020, 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 07, 2020 Sale$14.206,11586,8332,453,072Apr 07, 2020, 07:27 PM
Vivo Capital VIII, LLC10% OwnerApr 03, 2020 Sale$13.80300,0004,140,0002,458,445Apr 07, 2020, 07:27 PM
Vivo Capital VIII, LLC10% OwnerMar 09, 2020 Sale$19.5052810,2962,722,045Mar 11, 2020, 05:12 PM
Vivo Capital VIII, LLC10% OwnerFeb 07, 2020 Sale$22.005,905129,9102,723,843Feb 11, 2020, 08:00 PM
Vivo Capital VIII, LLC10% OwnerFeb 10, 2020 Sale$21.407,555161,6772,722,392Feb 11, 2020, 08:00 PM
Vivo Capital VIII, LLC10% OwnerFeb 04, 2020 Sale$22.8013,460306,8882,724,977Feb 06, 2020, 07:22 PM
Vivo Capital VIII, LLC10% OwnerJan 31, 2020 Sale$21.705,400117,1802,727,561Jan 31, 2020, 08:00 PM
Vivo Capital VIII, LLC10% OwnerJan 30, 2020 Sale$22.107,600167,9602,728,598Jan 31, 2020, 08:00 PM
Vivo Capital VIII, LLC10% OwnerJan 29, 2020 Sale$22.2013,920309,0242,730,057Jan 31, 2020, 08:00 PM
Fust Matthew KDirectorDec 16, 2019 Option Exercise$1.913,5006,68516,036Dec 18, 2019, 06:32 PM
Fust Matthew KDirectorDec 16, 2019 Sale$22.503,50078,75012,536Dec 18, 2019, 06:32 PM
Struthers Richard ScottPresident & CEOAug 05, 2019 Option Exercise$1.9110,00019,1001,225,805Aug 07, 2019, 07:31 PM
5AM Ventures IV, L.P.Former 10% holderJun 21, 2019 Sale$22.20250,0005,550,0002,267,797Jun 25, 2019, 07:03 PM
Vivo Capital VIII, LLC10% OwnerMar 20, 2019 Sale$22.25417,0009,278,2502,732,730Mar 25, 2019, 06:04 AM
5AM Ventures IV, L.P.10% OwnerMar 18, 2019 Sale$24.25154,8393,754,9542,507,797Mar 20, 2019, 04:48 PM
5AM Ventures IV, L.P.10% OwnerJan 22, 2019 Sale$21.88262,1535,734,5973,107,642Jan 24, 2019, 07:01 PM
PERCEPTIVE ADVISORS LLCDirectorJul 20, 2018 Buy$17.00400,0006,800,0002,587,953Aug 27, 2018, 06:12 PM
PERCEPTIVE ADVISORS LLCDirectorJul 18, 2018 Buy$21.30307,6486,552,902307,648Aug 27, 2018, 06:12 PM
5AM Ventures IV, L.P.10% OwnerJul 20, 2018 Buy$17.00115,0001,955,0003,359,309Jul 20, 2018, 07:02 PM
PERCEPTIVE ADVISORS LLCDirectorJul 20, 2018 Buy$17.00400,0006,800,0002,280,305Jul 20, 2018, 05:19 PM
Vivo Capital VIII, LLC10% OwnerJul 20, 2018 Buy$18.62353,1806,575,4213,025,339Jul 20, 2018, 04:50 PM
Krasner Alan SethChief Medical OfficerJul 20, 2018 Buy$17.002,00034,0002,000Jul 20, 2018, 04:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Struthers Richard ScottPresident & CEO04/04/2024380,025
Struthers Richard ScottPresident & CEO04/04/20242,013,561
Knight Jeff E.Chief Operating Officer03/22/2024719,400
Knight Jeff E.Chief Operating Officer03/22/20241,433,675
Pizzuti DanaChief Med and Dev Officer03/20/2024242,794
Pizzuti DanaChief Med and Dev Officer03/20/2024664,763
Fust Matthew KDirector03/20/20241,254,975
Fust Matthew KDirector03/20/20242,648,150
Pizzuti DanaChief Med and Dev Officer03/18/202415,676
Knight Jeff E.Chief Operating Officer03/18/2024163,354
Hassard JamesChief Commercial Officer03/18/202466,402
Betz Stephen F.Chief Scientific Officer03/18/2024139,402
Wilson MarcCFO03/18/2024151,912
Wilson MarcCFO03/19/2024297,881
Struthers Richard ScottPresident & CEO03/18/2024483,882
Betz Stephen F.Chief Scientific Officer01/25/2024111,780
Betz Stephen F.Chief Scientific Officer01/10/2024112,950
Pizzuti DanaChief Med and Dev Officer01/03/2024242,794
Pizzuti DanaChief Med and Dev Officer01/03/2024503,125
Wilson MarcCFO01/02/202492,800
Wilson MarcCFO01/02/2024354,700
Betz Stephen F.Chief Scientific Officer12/26/2023107,670
Pizzuti DanaChief Med and Dev Officer12/21/2023161,857
Pizzuti DanaChief Med and Dev Officer12/21/2023331,284
Betz Stephen F.Chief Scientific Officer12/11/202398,610
Betz Stephen F.Chief Scientific Officer11/27/202395,520
Struthers Richard ScottPresident & CEO11/09/202395,500
Struthers Richard ScottPresident & CEO11/02/20238,519
Struthers Richard ScottPresident & CEO11/03/20231,847,481
Struthers Richard ScottPresident & CEO11/02/202327,494
Struthers Richard ScottPresident & CEO11/03/20236,083,946
Wilson MarcCFO11/01/202392,800
Wilson MarcCFO11/01/2023287,500
Krasner Alan SethChief Medical Officer10/17/202384,070
Krasner Alan SethChief Medical Officer10/17/2023210,000
Struthers Richard ScottPresident & CEO08/14/202319,100
Struthers Richard ScottPresident & CEO07/13/2023288,095
Struthers Richard ScottPresident & CEO07/12/2023231,128
Struthers Richard ScottPresident & CEO07/11/2023491,094
Wilson MarcCFO06/20/2023185,600
Wilson MarcCFO06/20/2023617,403
Struthers Richard ScottPresident & CEO06/16/20231,040,500
Vivaldi Coelho RogerioDirector06/08/2023110,300
Pizzuti DanaChief Development Officer04/03/202368,522
Pizzuti DanaChief Development Officer04/05/2023132,624
Wilson MarcCFO03/16/202328,522
Struthers Richard ScottPresident & CEO03/16/202379,231
Krasner Alan SethChief Medical Officer03/16/202328,881
Knight Jeff E.Chief Operating Officer03/16/202310,049
Betz Stephen F.Chief Scientific Officer03/16/202324,139
Betz Stephen F.Chief Scientific Officer02/01/202361,238
Betz Stephen F.Chief Scientific Officer01/25/2023175,640
Betz Stephen F.Chief Scientific Officer01/17/202356,268
Betz Stephen F.Chief Scientific Officer01/03/202357,362
Betz Stephen F.Chief Scientific Officer12/15/202250,016
Betz Stephen F.Chief Scientific Officer12/01/202255,768
Betz Stephen F.Chief Scientific Officer11/15/202258,519
Betz Stephen F.Chief Scientific Officer11/01/202257,894
Betz Stephen F.Chief Scientific Officer10/17/202255,424
Struthers Richard ScottPresident & CEO10/12/202221,201
Betz Stephen F.Chief Scientific Officer10/03/202261,395
Betz Stephen F.Chief Scientific Officer09/15/202287,570
Betz Stephen F.Chief Scientific Officer09/07/202221,884
Betz Stephen F.Chief Scientific Officer05/20/202214,723
Betz Stephen F.Chief Scientific Officer09/01/202258,112
Knight Jeff E.Chief Operating Officer05/20/202220,091
Knight Jeff E.Chief Operating Officer07/26/202223,847
Fust Matthew KDirector07/13/20228,265
Fust Matthew KDirector07/13/2022119,455
Betz Stephen F.Chief Scientific Officer05/02/202265,252
Betz Stephen F.Chief Scientific Officer04/18/2022146,188
PERCEPTIVE ADVISORS LLC10% Owner04/18/20223,499,983
Struthers Richard ScottPresident & CEO04/13/20223,719,625
Struthers Richard ScottPresident & CEO04/05/2022541,225
Betz Stephen F.Chief Scientific Officer04/04/2022215,761
Betz Stephen F.Chief Scientific Officer04/01/202290,775
Betz Stephen F.Chief Scientific Officer03/31/202287,700
Betz Stephen F.Chief Scientific Officer03/15/202259,150
Madan AjayChief Development Officer03/01/2022178,920
Betz Stephen F.Chief Scientific Officer03/01/202261,617
Betz Stephen F.Chief Scientific Officer02/15/202258,213
Madan AjayChief Development Officer02/07/2022239,085
Betz Stephen F.Chief Scientific Officer02/01/202258,681
Krasner Alan SethChief Medical Officer01/19/202280,467
Krasner Alan SethChief Medical Officer01/19/2022142,080
Betz Stephen F.Chief Scientific Officer01/18/202297,073
Betz Stephen F.Chief Scientific Officer01/03/2022200,847
Betz Stephen F.Chief Scientific Officer12/28/202183,852
Betz Stephen F.Chief Scientific Officer12/15/2021136,826
Betz Stephen F.Chief Scientific Officer12/01/2021155,190
Betz Stephen F.Chief Scientific Officer11/16/202141,955
Betz Stephen F.Chief Scientific Officer11/15/2021151,619
Betz Stephen F.Chief Scientific Officer11/08/2021110,846
Betz Stephen F.Chief Scientific Officer11/05/2021352,195
Betz Stephen F.Chief Scientific Officer11/01/2021140,510
Fust Matthew KDirector11/01/202117,102
Fust Matthew KDirector11/01/2021228,327
Madan AjayChief Development Officer10/28/202177,660
Betz Stephen F.Chief Scientific Officer10/27/202171,991
Betz Stephen F.Chief Scientific Officer10/21/202121,984
PERCEPTIVE ADVISORS LLC10% Owner10/25/202123,759,999
Fust Matthew KDirector09/08/202111,548
Fust Matthew KDirector09/08/2021154,173
Struthers Richard ScottPresident & CEO09/07/2021250,000
Struthers Richard ScottPresident & CEO09/07/2021250,000
Struthers Richard ScottPresident & CEO09/07/2021250,000
Fust Matthew KDirector07/26/20219,550
Fust Matthew KDirector07/26/202197,950
Fust Matthew KDirector07/19/20219,550
Fust Matthew KDirector07/19/202197,500
Fust Matthew KDirector07/12/20219,550
Fust Matthew KDirector07/12/2021103,550
PERCEPTIVE ADVISORS LLC10% Owner04/08/20214,999,996
Struthers Richard ScottPresident & CEO12/03/202052,400
Struthers Richard ScottPresident & CEO12/02/202012,600
Struthers Richard ScottPresident & CEO07/16/2020253,108
Struthers Richard ScottPresident & CEO07/15/2020267,722
WIERENGA WENDALLDirector04/28/202018,490
PERCEPTIVE ADVISORS LLC10% Owner04/17/202014,999,992
Vivo Capital VIII, LLC10% Owner04/17/20201,302,809
Vivo Capital VIII, LLC10% Owner04/16/2020458,888
Vivo Capital VIII, LLC10% Owner04/15/20203,345,055
Vivo Capital VIII, LLC10% Owner04/07/202086,833
Vivo Capital VIII, LLC10% Owner04/03/20204,140,000
Vivo Capital VIII, LLC10% Owner03/09/202010,296
Vivo Capital VIII, LLC10% Owner02/07/2020129,910
Vivo Capital VIII, LLC10% Owner02/10/2020161,677
Vivo Capital VIII, LLC10% Owner02/04/2020306,888
Vivo Capital VIII, LLC10% Owner01/31/2020117,180
Vivo Capital VIII, LLC10% Owner01/30/2020167,960
Vivo Capital VIII, LLC10% Owner01/29/2020309,024
Fust Matthew KDirector12/16/20196,685
Fust Matthew KDirector12/16/201978,750
Struthers Richard ScottPresident & CEO08/05/201919,100
5AM Ventures IV, L.P.Former 10% holder06/21/20195,550,000
Vivo Capital VIII, LLC10% Owner03/20/20199,278,250
5AM Ventures IV, L.P.10% Owner03/18/20193,754,954
5AM Ventures IV, L.P.10% Owner01/22/20195,734,597
PERCEPTIVE ADVISORS LLCDirector07/20/20186,800,000
PERCEPTIVE ADVISORS LLCDirector07/18/20186,552,902
5AM Ventures IV, L.P.10% Owner07/20/20181,955,000
PERCEPTIVE ADVISORS LLCDirector07/20/20186,800,000
Vivo Capital VIII, LLC10% Owner07/20/20186,575,421
Krasner Alan SethChief Medical Officer07/20/201834,000
Load More Insider Transactions
FUNDS WITH A POSITION IN CRINETICS PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.5,345,1140.00485%10.31%Other
DRIEHAUS CAPITAL MANAGEMENT LLC5,039,9572.16%-1.8%Growth
ORBIMED ADVISORS LLC1,667,3601.18%-42.43%Other
GEODE CAPITAL MANAGEMENT, LLC1,352,6720.00504%6.54%Other
FISHER ASSET MANAGEMENT, LLC441,2950.0083%719.34%Other
VIVO CAPITAL, LLC350,0001.02%No changeOther
CANDRIAM S.C.A.288,0110.07%NewOther
FARALLON CAPITAL MANAGEMENT LLC122,9040.02%-66.04%Event Driven, Value
ALPS ADVISORS INC46,0250.01%14.13%Other
TUDOR INVESTMENT CORP ET AL39,7640.01%20.5%Event Driven, Other
UBS OCONNOR LLC30,000 (Call)0.00485%-50%Value
D. E. SHAW & CO., INC.17,0050.00053%-63.39%Other
RENAISSANCE TECHNOLOGIES LLC11,7000.00064%-92.85%Other
UBS OCONNOR LLC10,0380.03%-61.62%Value
AQR CAPITAL MANAGEMENT LLC6,6860.00045%NewOther
CHANGE IN SHARES OUTSTANDING FOR CRINETICS PHARMACEUTICALS INC
STOCK BUYBACKS FOR CRINETICS PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
18.43%
1Q
12/31/2023
06/30/2023
23.95%
2Q
12/31/2023
03/31/2023
24.80%
3Q
12/31/2023
12/31/2022
24.91%
4Q
12/31/2023
09/30/2022
25.12%
5Q
12/31/2023
06/30/2022
28.09%
6Q
12/31/2023
03/31/2022
41.00%
7Q
12/31/2023
12/31/2021
48.50%
8Q
12/31/2023
09/30/2021
75.61%
9Q
12/31/2023
06/30/2021
81.53%
10Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
18.43%
1Q
06/30/2023
23.95%
2Q
03/31/2023
24.80%
3Q
12/31/2022
24.91%
4Q
09/30/2022
25.12%
5Q
06/30/2022
28.09%
6Q
03/31/2022
41.00%
7Q
12/31/2021
48.50%
8Q
09/30/2021
75.61%
9Q
06/30/2021
81.53%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CRINETICS PHARMACEUTICALS INC
LOADING...